Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study

201329 citationsJournal Article

Authors

Aytekin Oğuz · Istanbul Medeniyet University

Marian Benroubi · Polyclinic General Hospital

Kerstin Brismar · Karolinska Institutet

Paulo Roberto Santana de Melo · Hospital Pedro Hispano

C. Morar · Association for Liberty and Equality of Gender

Simon Cleall · Eli Lilly (United Kingdom)

Joseph M. Giaconia

Abstract

Mean baseline HbA1c was high, indicating delayed initiation of insulin treatment. Blood pressure and lipids were suboptimally controlled. Insulin regimens varied between countries, changed little and resulted in similar HbA1c levels after 24 months.

Topics & Keywords

Diabetes Treatment and Management Diabetes Management and Research Diabetes, Cardiovascular Risks, and Lipoproteins

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Current Medical Research and Opinion

Volume 29, Issue 8, pp. 911-920

DOI: 10.1185/03007995.2013.803053

Field-Weighted Citation Impact: 1.17